R23	Appositive Attribute:T320 Head:T95
R24	Appositive Attribute:T320 Head:T96
R25	Appositive Attribute:T324 Head:T105
R26	Appositive Attribute:T324 Head:T106
R27	Appositive Attribute:T324 Head:T104
R28	PredicateNominative Attribute:T235 Head:T178
R29	PredicateNominative Attribute:T315 Head:T83
R30	PredicateNominative Attribute:T315 Head:T84
R31	Anaphora Anaphor:T248 Antecedent:T197
R32	Anaphora Anaphor:T249 Antecedent:T248
R33	Anaphora Anaphor:T250 Antecedent:T249
R34	Anaphora Anaphor:T313 Antecedent:T74
R35	Anaphora Anaphor:T313 Antecedent:T75
R36	Anaphora Anaphor:T340 Antecedent:T139
T1	Drug_Class 747 771	strong CYP 3A inhibitors
T2	Drug 781 793	ketoconazole
T3	Drug 795 807	itraconazole
T4	Drug 809 821	voriconazole
T5	Drug 823 835	cyclosporine
T6	Drug 837 850	telithromycin
T7	Drug 852 866	clarithromycin
T8	Drug 868 878	nefazodone
T9	Drug 884 893	ritonavir
T10	Drug_Class 945 998	drugs or herbal products that prolong the QT interval
T11	Drug_Class 1058 1087	phenothiazine anti-psychotics
T12	Drug_Class 1089 1114	tricyclic antidepressants
T13	Drug_Class 1124 1150	oral macrolide antibiotics
T14	Drug_Class 1156 1187	Class I and III antiarrhythmics
T17	Drug 199 205	MULTAQ
T18	Drug_Class 5305 5334	potassium-depleting diuretics
T21	Drug 5127 5133	MULTAQ
T22	Drug_Class 6952 6984	drugs prolonging the QT interval
T25	Drug 6582 6588	MULTAQ
T27	Drug_Class 7002 7016	phenothiazines
T28	Drug_Class 7018 7043	tricyclic antidepressants
T29	Drug_Class 7053 7074	macrolide antibiotics
T30	Drug_Class 7080 7111	Class I and III antiarrhythmics
T31	Drug 7697 7704	Digoxin
T33	Drug 7754 7765	dronedarone
T35	Drug 7806 7817	Dronedarone
T36	Drug 7840 7847	digoxin
T39	Drug 7933 7940	digoxin
T41	Drug 7995 8002	digoxin
T43	Drug_Class 8087 8161	Calcium channel blockers with depressant effects on the sinus and AV nodes
T44	Drug 8179 8190	dronedarone
T48	Drug 7415 7422	digoxin
T50	Drug 7494 7505	dronedarone
T53	Drug_Class 8236 8260	calcium channel blockers
T55	Drug 8476 8487	dronedarone
T56	Drug_Class 8518 8531	beta-blockers
T58	Drug_Class 8553 8566	beta-blockers
T59	Drug 8813 8825	ketoconazole
T60	Drug_Class 8843 8867	potent CYP 3A inhibitors
T61	Drug 8876 8888	itraconazole
T62	Drug 8890 8902	voriconazole
T63	Drug 8904 8913	ritonavir
T64	Drug 8915 8929	clarithromycin
T65	Drug 8935 8945	nefazodone
T68	Drug 8985 8996	dronedarone
T70	Substance 9124 9140	grapefruit juice
T71	Drug 9164 9170	MULTAQ
T73	Drug 9191 9202	dronedarone
T74	Drug 9309 9317	rifampin
T75	Drug_Class 9327 9342	CYP 3A inducers
T76	Drug 9351 9364	phenobarbital
T77	Drug 9366 9379	carbamazepine
T78	Drug 9381 9390	phenytoin
T79	Drug 9396 9410	St John's wort
T80	Drug 9445 9456	dronedarone
T82	Drug_Class 9562 9588	moderate CYP 3A inhibitors
T83	Drug 9534 9543	Verapamil
T84	Drug 9548 9557	diltiazem
T86	Drug 9602 9613	dronedarone
T88	Drug_Class 9643 9667	calcium channel blockers
T89	Drug 9858 9869	Dronedarone
T90	Drug 9880 9891	simvastatin
T93	Drug 9964 9975	simvastatin
T94	Drug_Class 10079 10086	statins
T95	Drug_Class 10088 10092	CYPs
T96	Drug_Class 10097 10109	transporters
T97	Drug_Class 10161 10187	CYP 3A and P-gp inhibitors
T98	Drug 10196 10207	dronedarone
T100	Drug_Class 10119 10125	statin
T102	Drug 10236 10247	Dronedarone
T103	Drug_Class 10274 10298	calcium channel blockers
T104	Drug 10300 10309	verapamil
T105	Drug 10311 10320	diltiazem
T106	Drug 10324 10334	nifedipine
T109	Drug_Class 10356 10380	calcium channel blockers
T110	Drug 10596 10607	Dronedarone
T111	Drug_Class 10679 10728	CYP 3A substrates with a narrow therapeutic range
T112	Drug 10646 10656	tacrolimus
T113	Drug 10658 10667	sirolimus
T117	Drug 10856 10867	Dronedarone
T118	Drug 10894 10905	propranolol
T119	Drug 10910 10920	metoprolol
T122	Drug_Class 10940 10953	beta-blockers
T123	Drug_Class 11034 11052	CYP 2D6 substrates
T124	Drug_Class 11070 11083	beta-blockers
T125	Drug_Class 11085 11110	tricyclic antidepressants
T126	Drug_Class 11116 11163	selective serotonin reuptake inhibitors (SSRIs)
T128	Drug 11220 11231	dronedarone
T129	Drug 11330 11341	Dronedarone
T130	Drug 11352 11359	digoxin
T133	Drug 11428 11435	digoxin
T135	Drug 11490 11497	digoxin
T137	Drug 11640 11650	dabigatran
T139	Drug 11690 11701	dronedarone
T140	Drug_Class 11745 11760	P-gp substrates
T142	Drug 11827 11838	dronedarone
T143	Drug 11877 11888	dronedarone
T144	Drug 11901 11911	S-warfarin
T145	Drug 11942 11950	warfarin
T148	Drug 12174 12185	dronedarone
T149	Drug_Class 12217 12236	oral anticoagulants
T152	Drug 12415 12423	warfarin
T153	Drug 12454 12465	dronedarone
T155	Drug 12496 12507	dronedarone
T156	Drug 12527 12535	warfarin
T157	Drug_Class 6867 6899	Drugs prolonging the QT interval
T158	Drug_Class 8768 8792	potent CYP 3A inhibitors
T159	Drug_Class 8061 8085	Calcium channel blockers
T160	Drug_Class 9508 9532	Calcium channel blockers
T161	Drug_Class 10210 10234	Calcium channel blockers
T162	Drug_Class 9286 9301	CYP 3A inducers
T163	Drug_Class 10836 10854	CYP 2D6 substrates
T164	Substance 9084 9100	Grapefruit juice
T165	Drug_Class 5199 5228	Potassium-Depleting Diuretics
T166	Drug_Class 10548 10564	CYP3A substrates
T167	Drug 7273 7280	Digoxin
T168	Drug 7567 7574	digoxin
T169	Drug 7945 7952	digoxin
T170	Drug 11321 11328	Digoxin
T171	Drug 11440 11447	digoxin
T172	Drug 9267 9275	Rifampin
T173	Drug_Class 8395 8408	Beta-blockers
T174	Drug_Class 10812 10825	Beta-blockers
T175	Drug 9845 9856	Simvastatin
T176	Drug 9892 9903	simvastatin
T177	Drug 8 19	dronedarone
T178	Drug 43 58	Dronedarone HCl
T179	Drug 2333 2344	dronedarone
T180	Drug 2703 2714	dronedarone
T181	Drug 5520 5531	Dronedarone
T182	Drug 5919 5930	dronedarone
T183	Drug 6176 6187	dronedarone
T184	Drug 6590 6601	Dronedarone
T185	Drug 7634 7645	dronedarone
T186	Drug 8732 8743	Dronedarone
T187	Drug 9817 9828	Dronedarone
T188	Drug 12304 12315	dronedarone
T189	Drug 8745 8757	Ketoconazole
T190	Drug 1244 1254	amiodarone
T191	Drug 11616 11626	Dabigatran
T192	Drug 11841 11849	Warfarin
T193	Drug 10526 10536	tacrolimus
T194	Drug_Class 10019 10026	statins
T195	Drug 0 6	MULTAQ
T196	Drug 1363 1369	MULTAQ
T197	Drug 1430 1436	MULTAQ
T198	Drug 1934 1940	MULTAQ
T199	Drug 2186 2192	MULTAQ
T200	Drug 2516 2522	MULTAQ
T201	Drug 2524 2530	MULTAQ
T202	Drug 2842 2848	MULTAQ
T203	Drug 3109 3115	MULTAQ
T204	Drug 3674 3680	MULTAQ
T205	Drug 3825 3831	MULTAQ
T206	Drug 3891 3897	MULTAQ
T207	Drug 4360 4366	MULTAQ
T208	Drug 4663 4669	MULTAQ
T209	Drug 4890 4896	MULTAQ
T210	Drug 5414 5420	MULTAQ
T211	Drug 5481 5487	MULTAQ
T212	Drug 5762 5768	MULTAQ
T213	Drug 10515 10524	Sirolimus
T214	Drug 11387 11391	P-gp
T215	Substance 5336 5345	Potassium
T344	SPAN 2071 2086	hospitalization
T345	SPAN 3438 3446	patients
T346	SPAN 11628 11636	Exposure
T234	ZeroArticleNP 21 27	tablet
T235	IndefiniteNP 62 81	a white fine powder
T236	ZeroArticleNP 485 507	NYHA Class IV symptoms
T237	IndefiniteNP 679 702	a functioning pacemaker
T238	ZeroArticleNP 747 771	strong CYP 3A inhibitors
T239	ZeroArticleNP 899 916	Drug Interactions
T240	DefiniteNP 1018 1026	the risk
T241	ZeroArticleNP 1156 1187	Class I and III antiarrhythmics
T242	DefiniteNP 1224 1240	the previous use
T243	IndefiniteNP 1412 1428	a pregnant woman
T244	DefiniteNP 1542 1553	the patient
T245	DefiniteNP 1595 1606	the patient
T246	DefiniteNP 1629 1649	the potential hazard
T247	IndefiniteNP 1653 1660	a fetus
T248	DemonstrativeNP 1500 1509	this drug
T249	DemonstrativeNP 1584 1593	this drug
T250	DefiniteNP 1782 1802	the active substance
T251	DefiniteNP 1816 1830	the excipients
T252	ZeroArticleNP 1888 1898	NYHA Class
T253	PersonalPronoun 2095 2097	it
T254	DefiniteNP 2106 2114	the risk
T255	ZeroArticleNP 1977 2004	NYHA Class IV heart failure
T256	DefiniteNP 2201 2209	the risk
T257	DefiniteNP 2780 2799	the first two weeks
T258	IndefiniteNP 2628 2654	a placebo-controlled study
T259	IndefiniteNP 2735 2752	an increased risk
T260	ZeroArticleNP 2803 2810	therapy
T261	ZeroArticleNP 2920 2954	appropriate antithrombotic therapy
T262	ZeroArticleNP 2960 2977	Drug interactions
T263	DefiniteNP 3119 3144	the postmarketing setting
T264	IndefiniteNP 3149 3158	a placebo
T265	IndefiniteNP 3370 3379	a history
T266	PersonalPronoun 3473 3477	they
T267	IndefiniteNP 3458 3469	a physician
T268	DefiniteNP 3835 3860	the postmarketing setting
T269	PersonalPronoun 4185 4187	it
T270	DefiniteNP 4148 4166	the first 6 months
T271	DefiniteNP 4267 4282	the development
T272	ZeroArticleNP 4098 4128	periodic hepatic serum enzymes
T273	ZeroArticleNP 4240 4253	serum enzymes
T274	ZeroArticleNP 4376 4389	serum enzymes
T275	DefiniteNP 4628 4646	the probable cause
T276	DefiniteNP 4714 4739	the observed liver injury
T277	IndefiniteNP 4690 4709	another explanation
T278	DefiniteNP 4900 4926	the post-marketing setting
T279	ZeroArticleNP 5199 5228	Potassium-Depleting Diuretics
T280	ZeroArticleNP 5305 5334	potassium-depleting diuretics
T281	DefiniteNP 5370 5386	the normal range
T282	DefiniteNP 5439 5455	the normal range
T283	IndefiniteNP 5540 5623	a moderate (average of about 10 ms but much greater effects have been observed) QTc
T284	DefiniteNP 5713 5736	the QTc Bazett interval
T285	IndefiniteNP 5974 5982	a result
T286	DefiniteNP 6033 6046	The elevation
T287	IndefiniteNP 6051 6064	a rapid onset
T288	IndefiniteNP 6074 6083	a plateau
T289	DefiniteNP 6221 6246	the postmarketing setting
T290	IndefiniteNP 6248 6258	Some cases
T291	DemonstrativeNP 6322 6335	these effects
T292	ZeroArticleNP 6365 6385	drug discontinuation
T293	IndefiniteNP 6506 6520	a hysterectomy
T294	ZeroArticleNP 6812 6818	7 DRUG
T295	DefiniteNP 7143 7161	the potential risk
T296	ZeroArticleNP 7080 7111	Class I and III antiarrhythmics
T297	DefiniteNP 7285 7298	the ANDROMEDA
T298	IndefiniteNP 7443 7460	an increased risk
T299	DefiniteNP 7630 7645	the dronedarone
T300	DefiniteNP 7720 7750	the electrophysiologic effects
T301	ZeroArticleNP 7853 7870	Drug Interactions
T302	DefiniteNP 7983 7991	the dose
T303	IndefiniteNP 8222 8232	a low dose
T304	ZeroArticleNP 8236 8260	calcium channel blockers
T305	ZeroArticleNP 8338 8355	Drug Interactions
T306	ZeroArticleNP 8501 8512	combination
T307	IndefiniteNP 8539 8549	a low dose
T308	ZeroArticleNP 8645 8662	Drug Interactions
T309	IndefiniteNP 8717 8728	Other Drugs
T310	IndefiniteNP 8762 8792	other potent CYP 3A inhibitors
T311	IndefiniteNP 8837 8867	other potent CYP 3A inhibitors
T312	IndefiniteNP 9280 9301	other CYP 3A inducers
T313	PersonalPronoun 9419 9423	they
T314	IndefiniteNP 9321 9342	other CYP 3A inducers
T315	ZeroArticleNP 9562 9588	moderate CYP 3A inhibitors
T316	IndefiniteNP 9629 9639	a low dose
T317	ZeroArticleNP 9643 9667	calcium channel blockers
T318	ZeroArticleNP 9745 9762	Drug Interactions
T319	IndefiniteNP 9832 9843	Other Drugs
T320	ZeroArticleNP 10079 10086	statins
T321	ZeroArticleNP 10119 10147	statin label recommendations
T322	ZeroArticleNP 10161 10187	CYP 3A and P-gp inhibitors
T323	DefiniteNP 10258 10270	the exposure
T324	ZeroArticleNP 10274 10298	calcium channel blockers
T325	IndefiniteNP 10342 10352	a low dose
T326	ZeroArticleNP 10356 10380	calcium channel blockers
T327	ZeroArticleNP 10458 10475	Drug Interactions
T328	IndefiniteNP 10542 10564	other CYP3A substrates
T329	IndefiniteNP 10673 10728	other CYP 3A substrates with a narrow therapeutic range
T330	IndefiniteNP 10830 10854	other CYP 2D6 substrates
T331	DefiniteNP 10878 10890	the exposure
T332	IndefiniteNP 11028 11052	Other CYP 2D6 substrates
T333	IndefiniteNP 11064 11083	other beta-blockers
T334	ZeroArticleNP 11116 11163	selective serotonin reuptake inhibitors (SSRIs)
T335	ZeroArticleNP 11237 11254	Drug Interactions
T336	DefiniteNP 11383 11403	the P-gp transporter
T337	DefiniteNP 11478 11486	the dose
T338	ZeroArticleNP 11559 11576	Drug Interactions
T339	PersonalPronoun 11666 11668	it
T340	PersonalPronoun 11712 11714	it
T341	IndefiniteNP 11739 11760	Other P-gp substrates
T342	ZeroArticleNP 12217 12236	oral anticoagulants
T343	DefiniteNP 12300 12321	the dronedarone group
